Stratification by risk factors predicts survival on the active treatment arm in a randomized phase II study of interferon-gamma plus/minus interferon-alpha in advanced renal cell carcinoma (E6890).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples